Successful Treatment Using Apixaban in a Patient on Hemodialysis with Uremic Calciphylaxis.
Moudi M AlasmariMona Yaser AlsheikhHend H MetwaliPublished in: Clinical, cosmetic and investigational dermatology (2022)
Calciphylaxis is a rare but serious condition in which microvessel occlusion occurs within the subcutaneous adipose tissue and dermis, leading to painful lesions. End-stage renal disease requiring hemodialysis and warfarin therapy can increase the risk of calciphylaxis. In this report, we describe the evaluation and treatment of a 75-year-old female patient with warfarin-induced calciphylaxis who presented unique symptoms. The patient required intensive care unit admission due to hemodynamic instability, which was treated with inotropes and broad-spectrum intravenous antibiotics. This description of the patient's unusual symptoms has the potential to provide insights needed to improve the diagnosis of future patients. Due to the unavailability of FDA-approved treatment for calciphylaxis, its management is based on data from observational studies and clinical experience.
Keyphrases
- end stage renal disease
- chronic kidney disease
- peritoneal dialysis
- case report
- intensive care unit
- adipose tissue
- atrial fibrillation
- venous thromboembolism
- newly diagnosed
- ejection fraction
- stem cells
- mesenchymal stem cells
- sleep quality
- low dose
- skeletal muscle
- oxidative stress
- climate change
- combination therapy
- cell therapy
- patient reported outcomes
- clinical evaluation